Moreover, using loss-of-function analysis in NSCLC cells, studies demonstrated that suppressed ANRIL expression can inhibit cell proliferation and induce cell apoptosis both in vitro and in vivo. The gene discussed is CDKN2B-AS1; the disease is non-small cell lung carcinoma.